Article: Coronavirus Disrupts NAD+ Metabolism, While Nicotinamide Riboside Decreases Viral Replication: Preclinical Findings

PrevNext
Metabolic Health Obesity Preclinical

Coronavirus Disrupts NAD+ Metabolism, While Nicotinamide Riboside Decreases Viral Replication: Preclinical Findings

Synopsis

Certain enzymes called PARPs, which use NAD+ to modify proteins, play a role in the body’s defense against coronaviruses. Researchers found that SARS-CoV-2 infection increases the levels of specific PARPs involved in antiviral responses and changes how cells produce NAD+. The activity of these PARPs depends on NAD+ availability. When NAD+ levels drop during infection, the antiviral functions of these enzymes are weakened. However, boosting NAD+ levels with NR or NAM reduced coronavirus replication. These findings suggest that supporting NAD+ production could be a way to support the immune response against coronaviruses like COVID-19.

Journal

Journal of Biological Chemistry

Share

Read more

Metabolic Health

Extracellular NAD+ Broken Down by Human Cells to Maintain Intracellular NAD+ Levels: Preclinical Findings

Synopsis Nicotinamide adenine dinucleotide (NAD+) is vital for cellular energy and signaling, and human cells replenish NAD+ by using extracellular precursors like nicotinamide (NAM), nicotinic ac...

Read more
Healthy Aging & Longevity

Gut Bacteria Support NAD+ Production: Preclinical Findings

Synopsis Nicotinamide adenine dinucleotide (NAD+) is essential for hundreds of cellular processes, including metabolism, DNA repair, and aging. How environmental factors affect NAD+ metabolism is ...

Read more